InMed Pharmaceuticals Announces $6 Million Private Placement Priced At $8.68/Share
InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ:INM), a leader in the research, development and manufacturing of rare cannabinoids, today announced that it has entered into a securities